|
Test Catalog
|
|
GARS (CMT2D) DNA Sequencing Test |
#228 |
|
| Type of Disorder: |
Peripheral Neuropathy |
|
| Typical Presentation: |
Sensory loss, feet ulcerations, distal motor weakness, hyperkeratosis; Normal Motor Nerve Conduction Velocities |
|
| Disease(s) tested for: |
CMT2D |
|
| Test Details |
|
| Test Code: |
228 |
|
| Profiles that contain this test: |
Complete CMT Evaluation, Dominant CMT Evaluation, Partial CMT- Axonal Only
|
|
| Informed Consent Required: |
Yes |
|
| Medicare ABN Required: |
No |
|
| Technical Information |
|
| Utility: |
Detect mutation in GARS gene |
|
| Methodology: |
DNA Sequencing, Polymerase Chain Reaction (PCR) |
|
| Reference Value: |
No sequence variation detected |
| CPT Coding |
|
|
The CPT codes provided are based on AMA guidelines
and are for informational purposes only. CPT coding
is the sole responsibility of the billing party.
Please direct any questions regarding coding to
the payer being billed.
|
| Stacked CPT Code(s): |
83891(1), 83898(17), 83904(17), 83909(17), 83912(1) |
|
| Shipping Considerations |
|
| Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form. |
|
| Preferred Specimen Requirements |
| Type: |
Whole blood |
| Minimum Volume: |
10 ml |
| Collection Tube: |
Lavender top (EDTA) |
|
| Storage Conditions: |
Room temperature, avoid freezing |
|
| Shipping Conditions: |
Room temperature, ship same day. Must arrive Monday-Friday. |
|
| Test Turnaround: |
2-3 weeks |
|
|
|
